"With so little accurate, specific information available on the impacts of healthcare 'reform,' accepting Comparative Effectiveness as 'inevitable' enables industry to take action and advance on at least one element," commented April Bright, General Manager of ORTHOWORLD.
Mr. Engelhardt went on to acknowledge that the task of proving clinical and economic benefits will reveal further opportunities.
John Engelhardt is one of more than 20 thought leaders presenting to hundreds of orthopaedic industry device company decision makers at OMTEC in Chicago, Illinois on June 16 and 17. For more information about OMTEC, please visit the ORTHOWORLD website at www.orthoworld.com.
About ORTHOWORLD
Founded in 1992, ORTHOWORLD is the only producer of strategic intelligence in the world solely focused upon the orthopaedic industry. Its singular mission is helping orthopaedic companies and individuals improve their performance.
For personal assistance, contact: | |
Christina Belski | |
Sales & Marketing Associate | |
ORTHOWORLD Inc. | |
440.543.2101 | |
christina@orthoworld.com | |
SOURCE ORTHOWORLD Inc.